A phase II clinical trial of peptichemio. Clinical screening cooperative group of European Organisation on Research on Treatment of Cancer (E.O.R.T.C)
- PMID: 339970
A phase II clinical trial of peptichemio. Clinical screening cooperative group of European Organisation on Research on Treatment of Cancer (E.O.R.T.C)
Similar articles
-
Clinical trial of peptichemio in solid tumors of childhood.Cancer Treat Rep. 1978 Jul;62(7):1015-9. Cancer Treat Rep. 1978. PMID: 356966 Clinical Trial.
-
Peptichemio in children with neoplastic disease.An Esp Pediatr. 1976 Dec;9(9):76-83. An Esp Pediatr. 1976. PMID: 797281 Clinical Trial.
-
Preliminary trials in the treatment of female gynaecological tumours by Peptichemio.Panminerva Med. 1976 May-Jun;18(5-6):170-4. Panminerva Med. 1976. PMID: 772520 Clinical Trial. No abstract available.
-
[Recent clinical experiences in the treatment of solid tumors with Peptichemio alone or in combination].G Ital Chemioter. 1974 Jan-Jun;21(1):33-5. G Ital Chemioter. 1974. PMID: 4619385 Clinical Trial. Italian. No abstract available.
-
Chemotherapy in childhood malignancies.J Fla Med Assoc. 1971 Nov;58(11):24-35. J Fla Med Assoc. 1971. PMID: 4330159 Review. No abstract available.
Cited by
-
New cancer chemotherapy drugs in Europe.Cancer Chemother Pharmacol. 1978;1(1):5-13. doi: 10.1007/BF00253141. Cancer Chemother Pharmacol. 1978. PMID: 373907 Review. No abstract available.
-
Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.Cancer Chemother Pharmacol. 1984;12(2):70-6. doi: 10.1007/BF00254592. Cancer Chemother Pharmacol. 1984. PMID: 6421500
-
Peptichemio induction therapy in myelomatosis.Cancer Chemother Pharmacol. 1982;8(1):9-16. doi: 10.1007/BF00292864. Cancer Chemother Pharmacol. 1982. PMID: 7094202
-
Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.Cancer Chemother Pharmacol. 1979;2(4):247-55. doi: 10.1007/BF00257189. Cancer Chemother Pharmacol. 1979. PMID: 287569